Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Typhoid in the United States and the risk to the international traveler.

× No keyword cloud information.

18 in total

Review 1. Management of children with prolonged fever of unknown origin and difficulties in the management of fever of unknown origin in children in developing countries.

Authors: G O Akpede; G I Akenzua
Journal: Paediatr Drugs Date: 2001 Impact factor: 3.022

2. Acalculous acute cholecystitis due to Salmonella typhi.

Authors: M E Avalos; M A Cerulli; R S Lee
Journal: Dig Dis Sci Date: 1992-11 Impact factor: 3.199

Review 3. Primary prevention and international travel: infections, immunizations, and antimicrobial prophylaxis.

Authors: G S Ferenchick; D H Havlichek
Journal: J Gen Intern Med Date: 1989 May-Jun Impact factor: 5.128

4. Cholera vaccination: a decision analysis.

Authors: D W MacPherson; M Tonkin
Journal: CMAJ Date: 1992-06-01 Impact factor: 8.262

Review 5. Treatment of traveller's diarrhoea. Economic aspects.

Authors: M A Thomson; I W Booth
Journal: Pharmacoeconomics Date: 1996-05 Impact factor: 4.981

6. Passive hemagglutination test for enteric fever.

Authors: B Petchclai; R Ausavarungnirun; S Manatsathit
Journal: J Clin Microbiol Date: 1987-01 Impact factor: 5.948

7. Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.

Authors: H Kollaritsch; E Furer; C Herzog; G Wiedermann; J U Que; S J Cryz
Journal: Infect Immun Date: 1996-04 Impact factor: 3.441

8. Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

Authors: J R Murphy; S S Wasserman; S Baqar; L Schlesinger; C Ferreccio; A A Lindberg; M M Levine
Journal: Clin Exp Immunol Date: 1989-02 Impact factor: 4.330

9. Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever.

Authors: B Hirschel; R Wüthrich; B Somaini; R Steffen
Journal: Eur J Clin Microbiol Date: 1985-06 Impact factor: 3.267

10. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.

Authors: S J Cryz; J U Que; M M Levine; G Wiedermann; H Kollaritsch
Journal: Infect Immun Date: 1995-04 Impact factor: 3.441